Dermira Shares Outstanding 2013-2018 | DERM

Dermira shares outstanding from 2013 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Dermira Annual Shares Outstanding
(Millions of Shares)
2017 41
2016 33
2015 27
2014 6
2013 1
2012 1
Dermira Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 42
Q2 2018 42
Q1 2018 42
Q4 2017 41
Q3 2017 42
Q2 2017 42
Q1 2017 37
Q4 2016 33
Q3 2016 35
Q2 2016 31
Q1 2016 30
Q4 2015 27
Q3 2015 28
Q2 2015 25
Q1 2015 25
Q4 2014 6
Q3 2014 1
Q2 2014 1
Q1 2014 1
Q4 2013 0
Q3 2013 1
Q4 2012 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.427B $0.005B
Dermira, Inc. is a specialty biopharmaceutical company. It is focused on bringing medical dermatology products to dermatologists and their patients. The Company markets topical small molecule therapeutics that target acne, sebaceous gland hyperactivity, and inflammatory skin diseases. Its late-stage product candidates comprise Cimzia which has completed Phase II clinical trials for the treatment of moderate-to-severe plaque psoriasis; DRM04 that is in a Phase IIb clinical trial for the treatment of hyperhidrosis or excessive sweating; and DRM01 which has completed a Phase IIa clinical trial for the treatment of acne. Dermira, Inc. is headquartered in Redwood City, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.973B 11.77
Zoetis (ZTS) United States $45.244B 30.98
Grifols (GRFS) Spain $14.428B 17.61
Tilray (TLRY) United States $10.390B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.090B 13.05
Neurocrine Biosciences (NBIX) United States $9.023B 1990.00
Ionis Pharmaceuticals (IONS) United States $7.117B 0.00
Nektar Therapeutics (NKTR) United States $6.465B 9.27
Impax Laboratories (AMRX) United States $5.751B 30.59
Catalent (CTLT) United States $5.556B 23.31
Sage Therapeutics (SAGE) United States $5.112B 0.00
United Therapeutics (UTHR) United States $4.913B 8.03
Loxo Oncology (LOXO) United States $4.870B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.002B 14.82
FibroGen (FGEN) United States $3.456B 0.00
Endo (ENDP) Ireland $3.033B 4.65
USANA Health Sciences (USNA) United States $2.883B 24.54
Madrigal Pharmaceuticals (MDGL) United States $2.251B 0.00
Xencor (XNCR) United States $2.152B 0.00
Heron Therapeutics (HRTX) United States $2.119B 0.00
Aerie Pharmaceuticals (AERI) United States $1.969B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.968B 265.94
Endocyte (ECYT) United States $1.936B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.752B 0.00
Zogenix (ZGNX) United States $1.677B 0.00
PTC Therapeutics (PTCT) United States $1.613B 0.00
TESARO (TSRO) United States $1.612B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.491B 18.24
Corcept Therapeutics (CORT) United States $1.446B 21.22
Spectrum Pharmaceuticals (SPPI) United States $1.367B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
Esperion Therapeutics (ESPR) United States $1.341B 0.00
Portola Pharmaceuticals (PTLA) United States $1.334B 0.00
Tricida (TCDA) United States $1.233B 0.00
TherapeuticsMD (TXMD) United States $1.132B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.098B 0.00
ImmunoGen (IMGN) United States $0.832B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.704B 0.00
Radius Health (RDUS) United States $0.693B 0.00
Karyopharm Therapeutics (KPTI) United States $0.667B 0.00
Flexion Therapeutics (FLXN) United States $0.621B 0.00
Collegium Pharmaceutical (COLL) United States $0.570B 0.00
GlycoMimetics (GLYC) United States $0.514B 0.00
ChemoCentryx (CCXI) United States $0.471B 37.28
Dova Pharmaceuticals (DOVA) United States $0.467B 0.00
OptiNose (OPTN) United States $0.465B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.448B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.444B 0.00
Odonate Therapeutics (ODT) United States $0.442B 0.00
Siga Technologies (SIGA) United States $0.431B 0.00
Aquestive Therapeutics (AQST) United States $0.430B 0.00
Xeris Pharmaceuticals (XERS) United States $0.428B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.419B 24.70
Forty Seven (FTSV) United States $0.407B 0.00
Zafgen (ZFGN) United States $0.402B 0.00
ArQule (ARQL) United States $0.400B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.394B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.391B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.364B 0.00
Depomed (ASRT) United States $0.344B 12.81
Mast Therapeutics (SVRA) United States $0.331B 0.00
Minerva Neurosciences (NERV) United States $0.317B 0.00
Aratana Therapeutics (PETX) United States $0.313B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Majesco Entertainment (PTE) United States $0.298B 0.00
KalVista Pharmaceuticals (KALV) United States $0.296B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.295B 0.00
CASI Pharmaceuticals (CASI) United States $0.286B 0.00
Translate Bio (TBIO) United States $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Affimed (AFMD) Germany $0.235B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Tyme Technologies (TYME) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.213B 0.00
Lannett Co Inc (LCI) United States $0.212B 1.85
Aldeyra Therapeutics (ALDX) United States $0.212B 0.00
ElectroCore (ECOR) United States $0.201B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.201B 0.00
Redhill Biopharma (RDHL) Israel $0.199B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Neon Therapeutics (NTGN) United States $0.193B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.188B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.183B 0.00
Ardelyx (ARDX) United States $0.173B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
ContraFect (CFRX) United States $0.166B 0.00
Molecular Templates (MTEM) United States $0.161B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.156B 0.00
MediWound (MDWD) Israel $0.154B 0.00
Melinta Therapeutics (MLNT) United States $0.150B 0.00
Recro Pharma (REPH) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
Champions Oncology (CSBR) United States $0.140B 0.00
DURECT (DRRX) United States $0.139B 0.00
Adherex Technologies (FENC) United States $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.129B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.122B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.110B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
CTI BioPharma (CTIC) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.093B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.093B 0.00
Achaogen (AKAO) United States $0.089B 0.00
Iterum Therapeutics (ITRM) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Otonomy (OTIC) United States $0.074B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.94
Neos Therapeutics (NEOS) United States $0.066B 0.00
Immune Design (IMDZ) United States $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Forward Pharma (FWP) Denmark $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 39.31
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.053B 0.00
Avenue Therapeutics (ATXI) United States $0.049B 0.00
Capnia (SLNO) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Trillium Therapeutics (TRIL) Canada $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Lipocine (LPCN) United States $0.034B 0.00
IsoRay (ISR) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 7.15
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Aradigm (ARDM) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 1.58
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00